Crowley-Nowick P A, Julian B A, Wyatt R J, Galla J H, Wall B M, Warnock D G, Mestecky J, Jackson S
Department of Microbiology, University of Alabama at Birmingham.
Kidney Int. 1991 Jun;39(6):1218-24. doi: 10.1038/ki.1991.154.
The prevalence of IgA nephropathy (IgAN) varies among racial groups, being most common among Caucasians and Orientals and rare in Blacks. Other investigators have hypothesized that the risk for IgAN may be influenced by the IgA2 allotype. It has been suggested that the rare Black patients with IgAN may be homozygous for the A2m(1) allele which predominates in Whites, but is less common in Blacks. In a multicenter study, 27 Black IgAN patients were enrolled to investigate this hypothesis and analyze the clinical course of disease in Blacks. The IgA2 allotypes of 18 Black patients and 14 controls were determined using restriction fragment length polymorphism analysis. Three patients were homozygous for the A2m(1) allele, four were homozygous for A2m(2) and 11 were heterozygous. The respective allelic frequencies of A2m(1) and A2m(2) were 0.47 and 0.53 and did not differ significantly from Black controls. Most clinical manifestations of disease did not significantly differ with respect to distribution of the two alleles, although the gender ratio differed between the homozygous A2m(1) and heterozygous patients. The presence of the A2m(1) allele did not increase the risk for IgAN, and the presence of the A2m(2) allele or homozygosity for this allele did not protect Blacks from the development of IgAN.
IgA肾病(IgAN)的患病率在不同种族群体中有所差异,在白种人和东方人中最为常见,而在黑人中则较为罕见。其他研究人员推测,IgAN的风险可能受IgA2同种异型的影响。有人提出,罕见的患IgAN的黑人患者可能是A2m(1)等位基因的纯合子,该等位基因在白人中占主导,但在黑人中较少见。在一项多中心研究中,招募了27名患IgAN的黑人患者,以研究这一假设并分析黑人患者的疾病临床过程。使用限制性片段长度多态性分析确定了18名黑人患者和14名对照者的IgA2同种异型。3名患者为A2m(1)等位基因的纯合子,4名是A2m(2)的纯合子,11名是杂合子。A2m(1)和A2m(2)各自的等位基因频率分别为0.47和0.53,与黑人对照者无显著差异。尽管纯合A2m(1)患者和杂合患者的性别比例不同,但疾病的大多数临床表现就两个等位基因的分布而言并无显著差异。A2m(1)等位基因的存在并未增加患IgAN的风险,A2m(2)等位基因的存在或该等位基因的纯合性也未使黑人免受IgAN的发展。